Clinical Genetics > Diagnostic Tests/Kits Products & Reviews

Effective genomic surveillance of SARS-CoV-2 variants begins with the right tools 

The BIOFIRE® ME Panel tests for a comprehensive set of 14 pathogens, including bacteria, viruses, and yeast, identifying the underlying cause of central nervous system infections, which in some cases can be life-threatening.

A powerful combination of multiplex PCR technology and syndromic testing to deliver a new standard for reliable, comprehensive diagnostics.

The BIOFIRE® BCID2 Panel tests for 43 targets associated with bloodstream infections, including gram-negative bacteria, gram-positive bacteria, yeast, and 10 antimicrobial resistance genes.

The BIOFIRE® GI Panel tests stool specimens for a comprehensive set of 22 gastrointestinal pathogens, including common targets associated with gastroenteritis.

The BIOFIRE® PN Panel identifies 33 targets from sputum-like (including endotracheal aspirate) and bronchoalveolar lavage (BAL)-like (BAL or mini-BAL) samples.

The BIOFIRE® RP2.1 Panel helps clinicians quickly diagnose respiratory tract infections by detecting pathogens like SARS-CoV-2, influenza, RSV, and many others.

The Streck ARM-D Kit, β-Lactamase is a multiplex real-time PCR kit for the rapid detection of β-lactam antibiotic resistance genes in Gram-negative bacteria. This comprehensive kit allows you to detect over 450 allelic variants in 9 clinically relevant carbapenemases, extended-spectrum beta-lactamases (ESBLs) and plasmid-mediated ampC gene families, KPC, NDM, OXA-48, IMP, VIM, DHA, CMY-2, CTX-M-14 and CTX-M-15. 

The Streck ARM-D Kit, OXA is a multiplex real-time PCR kit for the rapid detection of antibiotic resistance genes in Gram-negative bacteria. This comprehensive kit allows you to detect over 340 allelic variants within 6 OXA gene families, OXA-23, OXA-24/40, OXA-48, OXA-51, OXA-58 and OXA-143.

Check therapeutic drug monitoring test procedures with ready-to-use, liquid assayed multi-analyte Thermo Scientific™ MAS™ PAR™ TDM Controls, therapeutic drug controls with assayed values designed for therapeutic drugs and common immunoassayed test procedures on most automated instruments. Liquid, ready to use Features three significant levels Includes values for major automated analyzers

Full Screening for SARS-CoV-2 and variants including five notable mutations in S gene

For use as an aid in the detection of Mycobacterium tuberculosis (TB) infection

Appropriate for COVID-19 detection.

A highly specific molecular test for early detection of cervical cancer. The HPV OncoTect™ E6, E7 mRNA Kit is a unique detection method that measures both the number of transforming cells and the quantity of E6, E7 mRNA in each cell. These two measurements precisely assess the overexpression of E6, E7 mRNA in routine patient samples collected in ThinPrep® and Surepath™ vials to further refine accuracy and specificity of HPV t…

Optimize your HCV testing.

Comprehensive in-lab NIPT IVD solution including reagents, instruments, and software for accurate aneuploidy screening results in 26 hours.

Qualitative detection of promotor hypermethylation of 2 cervical cancer associated genes (FAM19A4 and hsa-miR124-2). Identify HPV positive women with high short-term progression to (pre)cancer.

Qualitative detection of 14 high-risk HPV types (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, 68) as well as putative HPV high risk type 67, with separate identification of HPV16 and 18 in one test. Fully clinically validated HPV screening method to identify women at risk for cervical (pre)cancer using either cervical scrape or self-collected vaginal sample.

Qualitative detection of 15 High-Risk HPV types with simultaneous genotyping of HPV16 and 18 in one tube. Fast. Simple. Accurate.

Qualitative detection and identification of 15 High-Risk HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, and 68. Fast. Simple. Accurate.

PreCursor-M AnoGYN is a methylation-specific molecular assay to detect promoter hypermethylation of the human genes ASCL1 and ZNF582  in bisulfite-converted DNA prepared from human samples, for instance formalin-fixed paraffin embedded anal biopsies or anal swab specimens.

Non-invasive marker for measuring sympathetic activity

Proteinase K from Tritirachium album ELEVATE  

Proteinase K from Tritirachium album ELEVATE

MammaPrint Provides Individualized Metastasis Risk Assessment for Your Breast Cancer Patients MammaPrint is the first FDA-cleared IVDMIA breast cancer recurrence assay. The unique 70-gene signature of MammaPrint provides you with the unprecedented ability to identify which early-stage breast cancer patients are at risk of distant recurrence following surgery, independent of Estrogen Receptor status and any prior treatment. Unl…